# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001571049-14-001071
Filing Date
2014-04-07
Accepted
2014-04-07 16:59:56
Documents
6
Effectiveness Date
2014-04-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE ADDITIONAL MATERIALS | t1400606_defa14a.htm | DEFA14A | 19539
2 | GRAPHIC | t1400606_pc1.jpg | GRAPHIC | 408233
3 | GRAPHIC | t1400606_pc2.jpg | GRAPHIC | 737848
4 | GRAPHIC | t1400606_pc3.jpg | GRAPHIC | 290838
5 | GRAPHIC | t1400606_pc4.jpg | GRAPHIC | 264916
6 | GRAPHIC | t1400606_pc5.jpg | GRAPHIC | 89396
| Complete submission text file | 0001571049-14-001071.txt |  | 2489330

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 14749210
SIC: 2834 Pharmaceutical Preparations